2018 annual financial data
Karyopharm Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -524.52%.
Operating income was -179,883,000 USD and net income was -178,407,000 USD.
Operating cash flow was -159,117,000 USD.
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 30,336,000 USD
- Operating income
- -179,883,000 USD
- Net income
- -178,407,000 USD
- Operating cash flow
- -159,117,000 USD